Hympavzi

Active Ingredient(s): Marstacimab-hncq
FDA Approved: * October 11, 2024
Pharm Company: * PFIZER INC
Category: Blood Clotting (Hemostasis)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hympavzi 150 mg/ml Subcutaneous Injection, Solution
NDC: 0069-1510
Labeler:
Pfizer Laboratories Div Pfizer Inc
Hympavzi 150 mg/ml Subcutaneous Injection, Solution
NDC: 0069-2151
Labeler:
Pfizer Laboratories Div Pfizer Inc